Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Cytosorbents (CTSO) over the last 14 years, with Q3 2025 value amounting to $190000.0.

  • Cytosorbents' Amortizatization of Intangibles rose 31304.35% to $190000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $697702.0, marking a year-over-year increase of 3015.98%. This contributed to the annual value of $264702.0 for FY2024, which is 5309.66% down from last year.
  • Cytosorbents' Amortizatization of Intangibles amounted to $190000.0 in Q3 2025, which was up 31304.35% from $190635.0 recorded in Q2 2025.
  • In the past 5 years, Cytosorbents' Amortizatization of Intangibles registered a high of $398035.0 during Q4 2021, and its lowest value of $45927.0 during Q1 2024.
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $64522.0 (2022), whereas its average is $127943.8.
  • Per our database at Business Quant, Cytosorbents' Amortizatization of Intangibles tumbled by 8607.13% in 2022 and then skyrocketed by 61794.34% in 2023.
  • Cytosorbents' Amortizatization of Intangibles (Quarter) stood at $398035.0 in 2021, then crashed by 86.07% to $55441.0 in 2022, then skyrocketed by 617.94% to $398035.0 in 2023, then plummeted by 68.17% to $126702.0 in 2024, then soared by 49.96% to $190000.0 in 2025.
  • Its Amortizatization of Intangibles was $190000.0 in Q3 2025, compared to $190635.0 in Q2 2025 and $190365.0 in Q1 2025.